[Pathology of cerebral edema. II. Experimental models and modifying agents].
Current experimental models of brain edema are described and evaluated for their contribution to the knowledge of basic processes involved in its production as well their contribution to the understanding of different clinical forms. The participation of each main pathogenic mechanism in a given experimental model is analyzed and proves to vary with each particular model and site studied. The importance of various experimental models in the evaluation of different therapeutic procedures directed to control the genesis and evolution of brain edema is stressed.
D000818:Animals; D001929:Brain Edema / Q000188:drug therapy / Q000209:etiology / Q000473:pathology*; D001930:Brain Injuries / Q000150:complications; D002545:Brain Ischemia / Q000150:complications; D001932:Brain Neoplasms / Q000150:complications; D002415:Cats; D004195:Disease Models, Animal; D005615:Freezing; D006973:Hypertension / Q000150:complications; D007038:Hypotonic Solutions / Q000633:toxicity; D010042:Ouabain / Q000633:toxicity; D011833:Radiation Injuries, Experimental / Q000150:complications; D051381:Rats; D014267:Triethyltin Compounds / Q000633:toxicity
D007038:Hypotonic Solutions; D014267:Triethyltin Compounds; D010042:Ouabain; C031575:triethyltin
Patología del edema cerebral. II. Modelos experimentales y agentes modificadores.